You are viewing the site in preview mode

Skip to main content

Peer Review reports

From: A retrospective study evaluating the effect of trastuzumab addition to carboplatin/paclitaxel on overall survival in patients with advanced-stage HER2/neu-overexpressing uterine serous carcinoma or carcinosarcoma

Original Submission
5 May 2024 Submitted Original manuscript
7 Jul 2024 Reviewed Reviewer Report
10 Jul 2024 Reviewed Reviewer Report
6 Oct 2024 Reviewed Reviewer Report
18 Nov 2024 Author responded Author comments - Chien-Hsing Lu
27 Nov 2024 Author responded Author comments - Chien-Hsing Lu
Resubmission - Version 2
18 Nov 2024 Submitted Manuscript version 2
5 Dec 2024 Reviewed Reviewer Report
19 Jan 2025 Author responded Author comments - Chien-Hsing Lu
Resubmission - Version 3
19 Jan 2025 Submitted Manuscript version 3
Publishing
28 Jan 2025 Editorially accepted
21 Feb 2025 Article published 10.1186/s12916-025-03916-3

You can find further information about peer review here.

Back to article page